Company Announcements

Latest announcements

Date and timeCompanyHeadlineSource
IMCD Spain expands its Pharmaceuticals presence with the acquisition of CobapharmaGlobeNewswire
Melexis Q1 2024 results – First quarter sales of 241.8 million EURGlobeNewswire
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact AwardsGlobeNewswire
Borregaard ASA: EBITDA1 of NOK 442 million in the 1st quarterGlobeNewswire
WithSecuren osavuosikatsaus 1.1. – 31.3.2024: Elements-yhtiön kannattavuus kehittyy suotuisasti, huolimatta hitaasta vuoden aloituksestaGlobeNewswire
WithSecure Interim report 1 January – 31 March 2024: Elements Company profitability developing positively, despite slow start of the yearGlobeNewswire
Wereldhave Trading update Q1 2024GlobeNewswire
TGS Q1 2024 Presentation and WebcastGlobeNewswire
Melexis Q1 2024 résultats – Chiffre d'affaires de 241.8 millions d'euros au premier trimestreGlobeNewswire
BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023GlobeNewswire
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidanceGlobeNewswire
Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l'exercice 2024GlobeNewswire
[Ad hoc-Mitteilung gemäss Art. 53 KR] Verkäufe der Roche-Gruppe steigen im ersten Quartal um 2% (CER); beide Divisionen Pharma und Diagnostics wachsen im hohen einstelligen Bereich ohne COVID-19-ProdukteGlobeNewswire
Norsk Hydro: Resilient in weak markets, positioned for growthGlobeNewswire
Norsk Hydro: Robust i et svakt marked, posisjonert for vekst GlobeNewswire
First quarter 2024 financial information: Good start to the yearGlobeNewswire
Information financière du premier trimestre 2024: Bon début d'année GlobeNewswire
Reminder: Unifiedpost Group Strategy Update Presentation on 30 April 2024GlobeNewswire
Vopak reports strong Q1 2024 results and increases FY 2024 outlookGlobeNewswire
Melexis Q1 2024 resultaten – Omzet van 241.8 miljoen EUR voor het eerste kwartaalGlobeNewswire
RNS announcements are delayed by up to an hour.
...